Brussels, 20 November 2026 – The International Fragrance Association (IFRA) welcomes the adoption of the Omnibus VI Regulation by the Council of the European Union. Following the European Parliament's vote on 22 October 2026, the decision concludes the legislative process launched by the European Commission's proposal in July 2025. The Regulation will enter into force 20 days after its publication in the Official Journal of the European Union, which is expected by the end of 2026.
"Policymakers have found a way to balance robust safety standards with the competitiveness of Europe's cosmetics and fragrance sector", said Alexander Mohr PhD, President of IFRA. "They listened to the evidence and have concluded a revised framework that keeps consumer safety first while removing hurdles that did nothing to improve it. That is good news for consumers, for innovation and for the European economy".
The automatic ban on ingredients classified as carcinogenic, mutagenic or toxic for reproduction remains the rule, and any exception still requires a positive opinion from the independent Scientific Committee on Consumer Safety (SCCS). What changes is that the route to an exception is now clearer and more predictable:
- Clear conditions: the SCCS can assess an ingredient for one or more uses across one or more cosmetic product categories, the compliance with food safety requirements condition has been removed, and a 'suitable alternative' is now defined – it must be safe, lower the overall risk, perform the same function just as well, be technically and economically feasible, and be available at scale.
- Natural ingredients: natural complex substances extracted from plants, such as essential oils, are not banned simply because one of their constituents is classified; the SCCS assesses that constituent instead.
- Predictable timelines: defined transition periods give companies time to reformulate and relabel, with longer periods where an ingredient has been found safe but a suitable alternative exists.
The fragrance, cosmetics and personal care industry is valued at € 180 billion, brings € 30 billion in export revenue to the European economy and underpins 3.5 million jobs.
The test now is implementation. Since the Cosmetic Products Regulation was adopted in 2009, the derogation procedure has never resulted in a derogation being granted. Omnibus VI fixes the procedure on paper, but it has not yet been tested in practice.
"The new rules are sound, but their effectiveness will ultimately depend on how they are implemented", said Aurélie Perrichet, Regional Director for Europe at IFRA. "A pragmatic approach will be essential, particularly when assessing the absence of suitable alternatives, where demonstrating that no viable alternative exists can be inherently complex. The burden of proof placed on industry must therefore be accompanied by clear, workable and proportionate expectations. This will require constructive discussions between the Commission and Member States, as well as practical implementation guidance, notably on the assessment of alternatives, to ensure that the derogation procedure can work effectively in practice. The first dossiers will show whether it succeeds in this".
IFRA and its Members stand ready to work with the European Commission, Member States and the SCCS to make the new framework work for consumers and companies alike.



